Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- GRAL
- Price
- 116.06
- Stock movement up
- +14.99 (14.83%)
- Company name
- GRAIL, LLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 4.52B
- Ent value
- 4.76B
- Price/Sales
- 31.90
- Price/Book
- 2.02
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 99.96%
- 1 year return (CAGR)
- 527.69%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
GRAL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 31.90 |
| Price to Book | 2.02 |
| EV to Sales | 33.55 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 38.98M |
| EPS (TTM) | -11.25 |
| FCF per share (TTM) | -9.13 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 141.83M |
| Gross profit (TTM) | -67.41M |
| Operating income (TTM) | -574.69M |
| Net income (TTM) | -406.24M |
| EPS (TTM) | -11.25 |
| EPS (1y forward) | -10.86 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -47.53% |
| Operating margin (TTM) | -405.20% |
| Profit margin (TTM) | -286.43% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 126.89M |
| Net receivables | 16.34M |
| Total current assets | 589.38M |
| Goodwill | 0.00 |
| Intangible assets | 1.89B |
| Property, plant and equipment | 112.24M |
| Total assets | 2.60B |
| Accounts payable | 3.41M |
| Short/Current long term debt | 58.59M |
| Total current liabilities | 77.43M |
| Total liabilities | 361.07M |
| Shareholder's equity | 2.24B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -328.71M |
| Capital expenditures (TTM) | 1.12M |
| Free cash flow (TTM) | -329.83M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -18.14% |
| Return on Assets | -15.62% |
| Return on Invested Capital | -18.02% |
| Cash Return on Invested Capital | -14.63% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 101.07 |
| Daily high | 118.84 |
| Daily low | 100.23 |
| Daily Volume | 1.39M |
| All-time high | 116.06 |
| 1y analyst estimate | 105.00 |
| Beta | - |
| EPS (TTM) | -11.25 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| GRAL | S&P500 | |
| Current price drop from All-time high | -9.27% | -1.40% |
| Highest price drop | -61.12% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -23.15% | -2.49% |
| Avg time to new high | 13 days | 6 days |
| Max time to new high | 155 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
4.52B
Marketcap category
Mid-cap
Description
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Employees
1000
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page